• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Solta acquires Sound Surgical Technologies

Article

Solta Medical will acquire Sound Surgical Technologies for $25.5 million in stock and $5 million in cash, the company announced.

 

Solta Medical will acquire Sound Surgical Technologies for $25.5 million in stock and $5 million in cash, the company announced.

Solta expects to close the transaction during the first quarter of this year. The transaction is expected to be accretive to Solta Medical’s quarterly earnings within 12 months, excluding acquisition and integration related charges, according to a company news release.

The acquisition will round out Solta’s product portfolio as the company envelops Sound Surgical’s ultrasound-based surgical and noninvasive body shaping products, including the VASER Lipo system, VASERsmooth, PowerX, and Origins.

“Sound Surgical provides Solta with a complementary, diversified product portfolio targeting the over $500 million body contouring market segment and the transaction meets our key acquisition criteria,” said Stephen J. Fanning, chairman, president and CEO of Solta Medical. “In combination with our rapidly growing Liposonix product line, the acquisition presents significant cross-selling opportunities to plastic surgeons and dermatologists, as well as expanded international sales potential.”

 

Related Videos
© 2024 MJH Life Sciences

All rights reserved.